Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Licenses CSD500 in Portugal

22 Mar 2017 07:00

RNS Number : 1458A
Futura Medical PLC
22 March 2017
 

For immediate release 22 March 2017

 

 

 

 

Futura Medical plc

("Futura" or the "Company")

Licenses CSD500 in Portugal

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that it has signed an exclusive licensing agreement with F Lima SA ("F Lima") for the marketing and distribution of CSD500, Futura's novel erectogenic condom, in Portugal.

It is expected that F Lima, an established Portuguese business that distributes consumer brands into a broad range of retail outlets including supermarkets and pharmacies, will launch CSD500 under the Blue Diamond brand name as soon as practicable.

The agreement with F Lima marks Futura's eighth licensing agreement for CSD500, which continues to be licensed exclusively on a regional basis to create a global distribution network.

The financial details of the agreement with F Lima are not being disclosed although Futura will receive royalties on all sales, with certain minimum performance criteria and associated royalty payments in the first two years.

Rui Miguel Lima, F Lima's General Manager, said: "We are very excited by the opportunity that Futura's innovative condom gives us in Portugal. We believe that we will be able to build a strong condom brand through CSD500 owing to the product's unique characteristics and its ability to meet customer needs."

James Barder, Futura's Chief Executive, commented: "We are delighted to sign this agreement with F Lima for the marketing and distribution of CSD500 in Portugal. F Lima is a well-established company with a strong track record of building brands in consumer healthcare."

For further information please contact:

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Liz Yong

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

 

Buchanan

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLFLLLDXFBBBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.